Trident Lifeline Limited
BSE: TLL
Prev Close
294.45
Open Price
291.7
Volume
13,200
Today Low / High
272.3 / 291.7
52 WK Low / High
222 / 339
Range
261 - 289
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 275.05, reflecting a change of -19.4 (-6.58855%). The expected target range on the BSE is 261 - 289. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Trident Lifeline Limited Graph
Trident Lifeline Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Trident Lifeline Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 275.05, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 275.05 | 277.80 | 250.02 - 305.58 |
| 280.55 | 224.44 - 336.66 | ||
| 283.30 | 198.31 - 368.29 | ||
| Bearish Scenario | 275.05 | 272.30 | 245.07 - 299.53 |
| 269.55 | 215.64 - 323.46 | ||
| 266.80 | 186.76 - 346.84 |
Overview of Trident Lifeline Limited
ISIN
INE0MKA01014
Industry
Medical - Pharmaceuticals
Vol.Avg
6,697
Market Cap
3,162,854,960
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 86.96 Cr | 45.55 Cr | 23.83 Cr | 0.2740 | 0.00 Cr | 0.00 Cr | 9.37 Cr | 11.75 Cr | 10.22 | 23.09 Cr | 0.1351 |
| 2024-03-31 | 44.63 Cr | 32.07 Cr | 12.56 Cr | 0.2814 | 0.04 Cr | 0.75 Cr | 8.07 Cr | 6.34 Cr | 5.52 | 10.27 Cr | 0.1421 |
| 2023-03-31 | 31.69 Cr | 22.58 Cr | 9.12 Cr | 0.2876 | 0.02 Cr | 0.54 Cr | 6.19 Cr | 6.02 Cr | 6.23 | 7.41 Cr | 0.1898 |
| 2022-03-31 | 21.77 Cr | 18.17 Cr | 3.60 Cr | 0.1654 | 0.02 Cr | 0.67 Cr | 2.58 Cr | 3.95 Cr | 3.43 | 3.31 Cr | 0.1814 |
| 2021-03-31 | 9.62 Cr | 7.63 Cr | 1.99 Cr | 0.2070 | 0.00 Cr | 0.30 Cr | 1.11 Cr | 0.63 Cr | 0.55 | 1.41 Cr | 0.0657 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.46 Cr | 156.01 Cr | 86.36 Cr | 64.4564 Cr | 54.03 Cr | 51.57 Cr | 28.24 Cr | 36.52 Cr | 0.00 Cr | 0.00 Cr | 10.72 Cr | 53.5547 Cr |
| 2024-03-31 | 6.65 Cr | 87.08 Cr | 33.13 Cr | 52.8965 Cr | 18.41 Cr | 11.76 Cr | 12.58 Cr | 20.37 Cr | 4.31 Cr | 0.00 Cr | 3.77 Cr | 20.2562 Cr |
| 2023-03-31 | 13.78 Cr | 62.57 Cr | 15.46 Cr | 45.6350 Cr | 7.69 Cr | -6.09 Cr | 7.17 Cr | 5.35 Cr | 1.19 Cr | 0.00 Cr | 3.34 Cr | 11.5340 Cr |
| 2022-03-31 | 0.16 Cr | 13.83 Cr | 9.06 Cr | 4.7757 Cr | 2.45 Cr | 2.30 Cr | 3.71 Cr | 0.31 Cr | 0.35 Cr | 0.00 Cr | -0.06 Cr | 7.5698 Cr |
| 2021-03-31 | 0.09 Cr | 11.44 Cr | 11.91 Cr | -0.4707 Cr | 4.53 Cr | 4.43 Cr | 5.30 Cr | 0.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 7.3372 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -11.5997 Cr | -13.8247 Cr | 19.7605 Cr | -22.6992 Cr | -4.1938 Cr | 2.4605 Cr | 0.0000 Cr | 0.0000 Cr | 23.6577 Cr | 0.0000 Cr | -7.8385 Cr |
| 2024-03-31 | 3.0771 Cr | -21.8201 Cr | 11.6126 Cr | -14.8141 Cr | -7.1250 Cr | 6.6543 Cr | -17.8912 Cr | 6.3439 Cr | 10.6177 Cr | 0.0000 Cr | -5.4157 Cr |
| 2023-03-31 | -18.7109 Cr | -10.4421 Cr | 42.7487 Cr | -25.6349 Cr | 13.6228 Cr | 13.7793 Cr | -6.9240 Cr | 6.5825 Cr | 5.9868 Cr | 0.0000 Cr | -3.4563 Cr |
| 2022-03-31 | -0.3405 Cr | -0.4452 Cr | 0.9277 Cr | -0.7957 Cr | 0.1420 Cr | 0.1566 Cr | -0.4552 Cr | 2.9836 Cr | -3.1049 Cr | 0.0000 Cr | 1.5594 Cr |
| 2021-03-31 | 1.0812 Cr | -0.5563 Cr | -0.5538 Cr | 0.5235 Cr | -0.0303 Cr | 0.0935 Cr | -0.5577 Cr | 0.8539 Cr | -1.9370 Cr | 0.0000 Cr | -4.3350 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 23.61 Cr | 10.95 Cr | 12.66 Cr | 0.5363 | 3.71 Cr | 3.06 Cr | 2.66 | 6.52 Cr | 0.1297 |
| 2025-03-31 | 46.05 Cr | 26.30 Cr | 7.22 Cr | 0.1568 | -0.29 Cr | 3.82 Cr | 3.33 | 10.02 Cr | 0.0830 |
| 2024-12-31 | 11.83 Cr | 3.72 Cr | 8.10 Cr | 0.6852 | 3.47 Cr | 2.79 Cr | 2.42 | 4.64 Cr | 0.2357 |
| 2024-09-30 | 15.45 Cr | 7.92 Cr | 7.53 Cr | 0.4873 | 3.89 Cr | 3.09 Cr | 2.69 | 4.59 Cr | 0.2003 |
| 2024-06-30 | 13.15 Cr | 9.34 Cr | 3.81 Cr | 0.2896 | 1.95 Cr | 2.29 Cr | 1.99 | 3.65 Cr | 0.1743 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.46 Cr | 0.00 Cr | 2.46 Cr | 27.68 Cr | 28.24 Cr | 90.37 Cr | 36.52 Cr | 156.01 Cr | 86.36 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -57.62 Cr |
| 2024-09-30 | 6.57 Cr | 0.00 Cr | 6.57 Cr | 19.83 Cr | 13.02 Cr | 61.33 Cr | 21.24 Cr | 97.86 Cr | 40.24 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 6.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -53.95 Cr |
| 2024-03-31 | 6.65 Cr | 0.00 Cr | 6.65 Cr | 13.38 Cr | 12.58 Cr | 51.97 Cr | 20.85 Cr | 87.08 Cr | 33.13 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 3.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born: 1994
Gender: male
Year Born:
Gender: male
Year Born: 1978
Gender: female
Year Born:
Gender: female
Year Born:
FAQs about Trident Lifeline Limited
The CEO is Hardik Jigishkumar Desai.
The current price is ₹275.05.
The range is ₹222-339.
The market capitalization is ₹316.29 crores.
The P/E ratio is 24.81.
The company operates in the Healthcare sector.
Overview of Trident Lifeline Limited (ISIN: INE0MKA01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹316.29 crores and an average daily volume of 6,697 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.